Clinical research in inflammatory bowel disease

December 2016

General Practitioners

Country of origin: USA

The Foundation for Clinical Research in Inflammatory Bowel Disease has launched myIBD.org, a new information site designed for those concerned about inflammatory bowel disease, the collective term for Crohn's disease, ulcerative colitis and indeterminate colitis. IBD affects over one million Americans and is a chronic, lifelong disease that has no known cause or cure.

"We want patients and their caregivers to be able to access the best information available from the leading authorities on IBD," said Jane Present, co-founder and executive director of the Foundation for Clinical Research in IBD. "That's why we worked with members of our scientific advisory committee, which includes IBD specialists and thought leaders from the country's leading institutions, to develop the content for myIBD.org."

The patient education section of the site includes an overview of IBD and the therapies used to treat the disease. In addition, myIBD.org includes transcripts of the Foundation's Advances in Inflammatory Bowel Disease patient education programmes, which it has hosted in over 70 cities throughout the United States. An "Ask the Specialist" section also provides a more in-depth look at questions that IBD patients and their caregivers may have.

In addition to providing information to patients, the Foundation for Clinical Research in IBD is striving to enhance the array of effective medications available to treat IBD, as well as to encourage young gastroenterologists to pursue clinical careers in IBD. Therefore, myIBD.org contains information devoted to clinicians that outlines the opportunities available through the Foundation. The site also includes information about current clinical trials and how patients can participate.

MyIBD.org is published by the non-profit organisation the Foundation for Clinical Research in IBD and underwritten through unrestricted educational grants from Abbott Laboratories, Centocor, Procter & Gamble Pharmaceuticals, Salix Pharmaceuticals, and Shire USA Pharmaceuticals.

Resources

Good Practice In Learning Disability Nursing November 2017 A document has been published to provide good practice guidance to support learning disability nursing to make a major...
Safeguarding Children In Whom Illness Is Fabricated Or Induced November 2017 A review of how Safeguarding Children in Whom Illness is Fabricated or Induced (2002) report makes a number of proposals...
Emergency Planning For NHS Organisations November 2017 Guidance on arrangements for service provision during a major incident has been published by the Department of Health. It...
Tackling Healthcare Associated Infections November 2017 Information on recent initiatives to tackle healthcare associated infections and details of new ideas to promote clean and...
Clean, Safe Care: Reducing Infections And Saving Lives November 2017 A document has been published which draws together recent initiatives to tackle healthcare associated infections and...
Seven Steps to Patient Safety in Mental Health November 2017 The National Patient Safety Agency (NPSA) has issued patient safety guidance for staff working in the area of mental health...
Meducation App November 2017 There are a ton of great medical education resources online but they can be scattered and hard to find. So Meducation does...
What Matters To Patients, Public And Staff October 2017 Research undertaken by the Department of Health has revealed what really matters to NHS staff and its users. Findings...
Helping People Who Are Unable To Make Some Decisions For Themselves October 2017 This booklet is one of a series of six on the Mental Capacity Act published by the Mental Capacity Implementation Programme...
Best Practice In Managing Risk October 2017 This framework is a guide for mental health professionals working with service users to assess risk. It underpins risk...
Search by Keyword